Metraipolis › archive › dc_4ff44485fa04

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia — Europe PMC PMID:42100588

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42100588
DOI: 10.1210/jcemcr/luag086
License (as archived): solo-consultazione
Archived: 2026-11-02T17:53:01.076Z
SHA-256 of the archived text: e33f06770bb51398edca879bdfe730df5d8bb454bac41a9afda951a6c051e534
Stable URL of this page: https://metraipolis.com/documento/dc_4ff44485fa04

How to cite

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia — Europe PMC PMID:42100588 — Europe PMC (en), https://europepmc.org/article/MED/42100588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ff44485fa04 (Metraipolis archive dc_4ff44485fa04, sha256 e33f06770bb51398edca879bdfe730df5d8bb454bac41a9afda951a6c051e534)

BibTeX

@misc{dc4ff44485fa04,
  title = {Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia — Europe PMC PMID:42100588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42100588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ff44485fa04; sha256 e33f06770bb51398edca879bdfe730df5d8bb454bac41a9afda951a6c051e534},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42100588. Agents can read the archived copy with the MCP tool read_document.